Medically reviewed by Dr Sin Yong · Last reviewed · 10 min read · Assessed personally by Dr Sin Yong · Jump to questions
Acne on the back, chest and shoulders is the neglected half of the disease: present in roughly half of facial-acne patients, less discussed, harder to reach, slower to treat — and more likely to leave the marks that matter, because truncal skin scars and pigments more stubbornly than the face. It also hosts the great impostor: fungal folliculitis that no acne product touches.
WhatsApp Dr Sin Yong →Back and body acne (truncal acne) is acne on the back, chest and shoulders, where larger, denser oil glands, thicker skin and constant occlusion from clothing and sweat shape how it behaves. Assessment starts by separating true acne from Malassezia (fungal) folliculitis, because the two look alike but need different treatment.


The truncal reviews describe a follicular landscape different from the face: larger, denser sebaceous units set in thicker skin, occluded daily by clothing and — in a gym-going, tropical population — hours of sweat-soaked compression wear [1]. The same reviews flag the asymmetric stakes: the chest, shoulders and upper back are the body's most keloid-prone territory, and truncal post-inflammatory pigment outlasts its facial cousin. A backne cycle tolerated for years often bills its cost in permanent raised or pigmented marks that the acne itself never warned about.
The trunk hosts the classic impostor. True acne is polymorphic — comedones, papules, pustules and deeper lesions of mixed ages. Malassezia folliculitis is monomorphic — crops of near-identical, often itchy bumps across the upper back, chest and shoulders — and it laughs at benzoyl peroxide while worsening under oral antibiotics. The two frequently coexist in the same patient, which is why a trunk that has defeated years of acne products deserves a diagnosis before another product: half the failure stories are simply the wrong organism.
The consensus recommendations for truncal acne support the same evidence architecture as facial disease, adapted for acreage [2]: wash-format topicals (benzoyl peroxide washes suit large surfaces), topical retinoids in trunk-practical formats, and earlier escalation to systemic therapy — antibiotic courses in defined roles, hormonal therapy where the pattern indicates, and isotretinoin for severe or scarring disease — because reach and adherence limit what creams achieve across a back. In-clinic, the back acne programme adds laser- and light-based control of active lesions, with the acne programme covering the medical arm; leftover marks are triaged between PIH and true scarring. Habits earn their keep here: showering out of sweaty kit promptly, breathable fabrics, and not scrubbing.
Scrubbing brushes and loofahs on inflamed follicles — mechanical insult on a field already inflamed. Harsh soaps 'to dry it out' — barrier damage without follicular effect. Antibiotics alone, indefinitely — resistance and the fungal-overgrowth trap. Sunbathing the back clear — a temporary blur bought with pigment risk on PIH-prone skin. And ignoring it because nobody sees it — the trunk is exactly where quiet acne leaves loud, keloid-shaped receipts.
“Back acne is the quiet half of the disease with the loudest scars — the chest and shoulders forgive breakouts worst of anywhere on the body.”
— Dr Sin Yong
Back acne is the quiet half of the disease with the loudest scars — the chest and shoulders keloid more readily than anywhere else. Half the failed bacne stories I hear were treating the wrong organism entirely; fungal folliculitis shrugs at every acne wash. Diagnose the trunk before buying a fourth product for it.
Use the short enquiry form instead →
Leave your name, mobile number and email and the clinic will contact you directly. No obligation.
Prefer a preliminary view first? You can also WhatsApp a photo of the area for Dr Sin Yong to review before you decide on a visit.
| Type / look-alike | How to recognise it | What it needs | What does not work |
|---|---|---|---|
| True truncal acne (polymorphic) | Mixed comedones, papules, pustules and deeper lesions of different ages | Wash-format topicals, retinoids; systemic therapy if moderate to severe | Scrubbing, harsh drying soaps, sunbathing |
| Malassezia (fungal) folliculitis (look-alike) | Crops of near-identical, often itchy bumps on upper back, chest, shoulders | Organism diagnosis and antifungal treatment | Benzoyl peroxide, or antibiotics alone |
| Mixed acne and fungal folliculitis | Both patterns together; failure of years of acne products | Diagnosis of both, then treatment of each | Another acne product without a diagnosis |
| Post-inflammatory marks (flat pigment) | Flat brown or red marks left after spots settle | Control of active spots, sun protection and review | Aggressive scrubbing or sun exposure |
| Raised or keloid scars | Firm, raised scars on chest, shoulders or upper back | Early assessment and scar-directed treatment | Ignoring it because nobody sees it |
Occlusion and sweat contribute, but the cause is follicular; scrubbing harder worsens inflammation rather than helping.
Uniform itchy bumps are often fungal folliculitis, which does not respond to acne washes.
The trunk's follicles are their own ecosystem — larger sebaceous units, thicker skin and clothing occlusion. Plenty of patients express the disease in one territory only.
Sweat-soaked compression wear and shared equipment aggravate both true acne and fungal folliculitis. Prompt post-workout showers and breathable kit measurably help; they rarely suffice alone.
Either the disease needs more than topicals — a common truth across a back's acreage — or the bumps are fungal folliculitis, which no acne wash treats. Diagnosis beats a fourth product.
Pigmented flat marks fade over months and respond to PIH treatment. Raised chest and shoulder scars are keloid-family — permanent without targeted treatment, and the reason truncal acne deserves earlier control.
Defined courses have a role within a plan — but antibiotics alone, open-endedly, invite resistance and fungal overgrowth. Severe or scarring truncal disease often warrants the isotretinoin conversation instead.
Control first, marks second — active disease keeps printing new marks behind every treatment. The sequencing protects both results.
Medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last updated 7 September 2026 · Editorial policy